Novo Nordisk – GLP-1 RA Therapy

 

GLP-1 RA Therapy
19:47

Novo Nordisk – GLP-1 RA Therapy

GLP-1 RA Use in Clinical Practice: Examining Trial Data and T2D Treatment Algorithms

FEATURING Lisa Coco, Carolina Solis-Herrera
  • 171 views
  • May 3, 2022
23:07

Novo Nordisk – GLP-1 RA Therapy

Examining Clinical Trial Data on GLP-1 RAs and Basal Insulin in T2D: Approaches to Intensification

FEATURING Lisa Coco, James R. Gavin Iii
  • 111 views
  • May 3, 2022
19:36

Novo Nordisk – GLP-1 RA Therapy

GLP-1 RAs and Cardiovascular Considerations in T2D Patients With ASCVD

FEATURING Lisa Coco, Joshua M. Stolker
  • 126 views
  • May 3, 2022
20:18

Novo Nordisk – GLP-1 RA Therapy

Importance of Patient Education and Support in Type 2 Diabetes Patients

FEATURING Lisa Coco, Jennifer Goldman
  • 177 views
  • May 3, 2022
08:42

Novo Nordisk – GLP-1 RA Therapy

T2D Treatment After Metformin: What Does This GLP-1 RA Head-to-Head Trial Data Show?

FEATURING Richard E Pratley
  • 2,469 views
  • May 26, 2021
  • 5
08:56

Novo Nordisk – GLP-1 RA Therapy

Reaching A1C Goals With GLP-1 RA Injectables: What Does This Trial Data Show?

FEATURING Richard E Pratley
  • 913 views
  • May 26, 2021
  • 3
09:22

Novo Nordisk – GLP-1 RA Therapy

GLP-1 RA as a First Injectable for T2D: What Is the Safety and Efficacy of Two Different GLP-1 RA Options From This Trial?

FEATURING Richard E Pratley
  • 1,362 views
  • May 26, 2021
  • 3
01:52

Novo Nordisk – GLP-1 RA Therapy

T2D Treatment After Oral Agents: What Is the Next Step?

FEATURING Craig Wierum, Lisa Coco
  • 1,112 views
  • May 26, 2021
  • 1
01:13

Novo Nordisk – GLP-1 RA Therapy

ADA Guidelines for T2D: What Is the Preferred Next Step After Oral Agents?

FEATURING Craig Wierum, Lisa Coco
  • 1,144 views
  • May 26, 2021
  • 2
11:40

Novo Nordisk – GLP-1 RA Therapy

GLP-1 RA as a First Injectable for T2D: Is It as Effective as Basal Insulin

FEATURING Craig Wierum, Lisa Coco
  • 1,295 views
  • May 26, 2021
  • 4